Literature DB >> 4071610

The effect of verapamil on renal function after warm and cold ischemia in the isolated perfused rat kidney.

J I Shapiro, C Cheung, A Itabashi, L Chan, R W Schrier.   

Abstract

The potential usefulness of verapamil, a calcium channel blocker to renal allograft preservation, was investigated using the isolated perfused rat kidney. Two models of ischemic injury were used. In the first model, rat kidneys were exposed to 40 min of 37 degrees C ischemia on the perfusion circuit. Addition of verapamil in doses of 2.5, 5, and 100 microM concentration to the perfusate significantly improved inulin clearance (Cin) and total sodium absorption (TNa) in the hour of reperfusion following ischemia. Regeneration of adenosine triphosphate (ATP) and total adenine nucleotide TAN levels during reperfusion following warm ischemia were also significantly higher in verapamil-treated kidneys. In the second model, rat kidneys were flushed in situ with Collins C2 solution and stored at 0 degrees C for 8 hr. After this period of cold ischemia, they were perfused on a perfusion circuit with perfusion media. Verapamil 2.5 microM was absent from both flush and perfusate (control), or added to just the flush, both the flush and perfusate, or just the perfusate. Addition of verapamil to the flush or the flush and perfusate significantly improved Cin, urine flow rate (V) and TNa during reperfusion, compared with control. Addition of verapamil to just the perfusate did not effect Cin, TNa, or V but did significantly increase RPF. These findings suggest the verapamil may protect against organ damage occurring during both warm and cold ischemia in the absence of any systemic effects and thus may be useful for renal allograft preservation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4071610     DOI: 10.1097/00007890-198512000-00004

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  11 in total

1.  Intrarenal infusion of gallopamil in acute renal failure. A preliminary report.

Authors:  D Lumlertgul; O Wongmekiat; C Sirivanichai; P Hundagoon; M Keoplung; J D Conger; R W Schrier
Journal:  Drugs       Date:  1991       Impact factor: 9.546

Review 2.  Cellular mechanism of ischemic acute renal failure: role of Ca2+ and calcium entry blockers.

Authors:  R W Schrier; J Hensen
Journal:  Klin Wochenschr       Date:  1988-09-15

Review 3.  Calcium handling by renal tubules during oxygen deprivation injury to the kidney prior to reoxygenation.

Authors:  T J Burke; H Singh; R W Schrier
Journal:  Cardiovasc Drugs Ther       Date:  1990-10       Impact factor: 3.727

4.  Smooth muscle calcium and endothelium-derived relaxing factor in the abnormal vascular responses of acute renal failure.

Authors:  J D Conger; J B Robinette; R W Schrier
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

5.  The effect of L-type Ca2+ channel blockers on anoxia-induced increases in intracellular Ca2+ concentration in rabbit proximal tubule cells in primary culture.

Authors:  U M Rose; R J Bindels; A Vis; J W Jansen; C H Van Os
Journal:  Pflugers Arch       Date:  1993-06       Impact factor: 3.657

6.  Renal failure in haemorrhagic shock in dogs: salutary effects of the calcium entry blocker felodipine.

Authors:  M S Chintala; B S Jandhyala
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-04       Impact factor: 3.000

7.  The effect of verapamil on the prevention of ischemia/reperfusion injury in the experimental retroperitoneoscopic donor nephrectomy model.

Authors:  M Demirbas; C Guler; M Samli; T Köken; C Dincel; C Polat
Journal:  Surg Endosc       Date:  2004-06-23       Impact factor: 4.584

8.  Protection against hypoxic injury of rat proximal tubules by felodipine via a calcium-independent mechanism.

Authors:  S M Peters; M J Tijsen; R J Bindels; C H van Os; J F Wetzels
Journal:  Pflugers Arch       Date:  1995-11       Impact factor: 3.657

Review 9.  Do calcium channel blockers have renal protective effects?

Authors:  G P Reams
Journal:  Drugs Aging       Date:  1994-10       Impact factor: 3.923

10.  In vitro and in vivo protective effect of atriopeptin III on ischemic acute renal failure.

Authors:  M Nakamoto; J I Shapiro; P F Shanley; L Chan; R W Schrier
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.